comparison of glp 1 agonists Frontiers GLP-1 Receptor Agonist Market Size

Hematologic cancers among patients with type 2 diabetes prescribed GLP-1 receptor agonists

Significant improvements were observed in comorbidities, including reductions in obstructive sleep apnea ( 30%), hypertension ( 40%), and arthralgia ( 56.5%)

If hair shedding begins three to six months after starting GLP-1 therapy and is diffuse rather than patchy or patterned, GLP-1 related telogen effluvium is the most likely cause

But it is an important shift

Knerr PJ, Mowery SA, Douros JD, et al

Most patients who stop GLP-1 treatment regain a significant portion of the weight they lost, which is why discontinuation is generally not recommended unless side effects or other clinical concerns warrant it